Limfoma Dokter Terbaik di Israel - TOP-25 dokter

Ahli limfoma terkemuka di Sourasky Medical Center dengan pengalaman onkologi spesialis selama lebih dari 30 tahun.

• Associate Professor Onkologi di Tel-Aviv University
• Anggota fakultas ESMO yang berspesialisasi dalam sarkoma dan limfoma
• Latar belakang penelitian yang luas dengan kolaborasi di Weizmann Institute
• Mantan kepala Divisi Onkologi di Sourasky
• Anggota aktif di ASCO dan IASLC untuk kemajuan onkologi

Dr. Ram Ron bekerja di Pusat Medis Sourasky yang ternama di Tel Aviv, menghadirkan keahlian terfokus pada kasus limfoma yang kompleks.

• Lebih dari 25 tahun pengalaman klinis di bidang onkologi
• Pelatihan fellowship di bidang onkologi untuk pengetahuan khusus
• Bekerja dalam departemen onkologi multidisiplin yang besar
• Diagnosis dan perencanaan perawatan tingkat lanjut

Beliau telah melakukan ratusan transplantasi sel punca, sebuah perawatan kunci untuk limfoma. Dr. Ron Ram adalah ahli onkologi bersertifikat triple board di Sourasky Medical Center (Ichilov).

• Berspesialisasi khusus dalam Hematologi dan Onkologi Medis
• Menyelesaikan fellowship onkologi di New York Medical College
• Berkontribusi pada lebih dari 30 artikel ilmiah dan buku teks medis
• Berpengalaman dalam pengobatan penyakit dalam dan kanker hematologi tingkat lanjut

Dr. El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat untuk anak-anak di Sourasky Medical Center.

• Memimpin Departemen Onkohematologi dan Onkologi Anak di Rumah Sakit Anak Dana Dwek
• Spesialisasi dalam transplantasi sumsum tulang dan darah tali pusat anak
• Menerbitkan 50 makalah penelitian di bidang medis
• Anggota American Society of Hematology dan Israeli Society for Pediatric Hematooncology
• Menimba pengalaman di City of Hope Hospital di Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Kepala Hematologi dan Limfoma di Tel-Aviv Medical Center – Prof. Joffe spesialis dalam kasus limfoma kompleks dengan pelatihan lanjutan di Memorial Sloan Kettering.

• 35 tahun pengalaman dalam hematologi-onkologi
• Spesialisasi dalam limfoma sel B besar difus dan limfoma SSP
• Memimpin uji klinis untuk imunoterapi limfoma baru
• Dokter senior di Memorial Sloan Kettering Cancer Center
• Fokus pada pengobatan personal berdasarkan profil genetik

Prof. Shapira berspesialisasi dalam transplantasi sumsum tulang dan memimpin tim perawatan di Sourasky Medical Center.

• Lulus dari fakultas kedokteran Hebrew University pada tahun 1999
• Mengambil spesialisasi penyakit dalam di Hadassah Medical Center
• Sebelumnya menjabat sebagai dokter senior di departemen Transplantasi Sumsum Tulang
• Berbicara dalam bahasa Inggris dan Ibrani untuk komunikasi yang jelas

Dr. Dror Levin memimpin departemen hematologi onkologi pediatrik di Sourasky Medical Center, yang berspesialisasi dalam kelainan darah dan kanker tulang pada anak-anak.

• Dokter spesialis anak senior di Rumah Sakit Anak 'Dana' dengan pengalaman luas
• Koordinator perawatan kanker tulang (sarkoma) pada anak-anak
• Menempuh pelatihan di Rizzoli Orthopaedic Institute di Bologna – pemimpin dunia dalam ortopedi
• Anggota ISPHO (Masyarakat Hematologi Onkologi Pediatrik Israel)

Kepala Institut Hemato-Onkologi di Sourasky Medical Center – pusat utama untuk perawatan limfoma dan leukemia sejak tahun 2003.

• 31 tahun praktik sebagai onkohematolog
• Spesialisasi dalam mengobati limfoma, tidak hanya onkologi umum
• Memimpin Departemen Transplantasi Sumsum Tulang

Dr. Yair adalah ahli hematologi terkemuka dengan berbagai penghargaan atas keunggulan dalam penelitian dan pengobatan limfoma di Tel-Aviv Sourasky Medical Center.

• Spesialisasi dalam kasus leukemia limfositik kronis
• Penerima lebih dari 10 penghargaan bergengsi di bidang hematologi
• Anggota Asosiasi Hematologi Israel dan Amerika
• Menjalani pelatihan di lembaga medis terkemuka di Israel

Diakui sebagai salah satu dokter terbaik Israel oleh Forbes pada 2019-2020, Dr. Gal Goldstein adalah Kepala Onkologi Anak di Rumah Sakit Hadassah.

• Mengambil spesialisasi eksklusif dalam hemato-onkologi anak selama lebih dari 20 tahun
• Ahli dalam perawatan lanjutan seperti transplantasi sumsum tulang haploidentik
• Fokus mendalam pada kanker masa kanak-kanak tertentu, termasuk retinoblastoma
• Anggota aktif perkumpulan onkologi internasional seperti SIOP
• Menerapkan pengobatan presisi untuk mempersonalisasi rencana perawatan

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Spesialisasi khusus dalam limfoma, memfokuskan praktiknya pada kanker darah yang kompleks ini di Rambam Medical Center.

• Ahli hematologi dengan keahlian mendalam dalam subtipe limfoma
• Memberikan pengobatan terarah untuk kondisi spesifik ini
• Bertugas di rumah sakit perawatan tersier dan penelitian terkemuka

Karen Drumea adalah seorang spesialis radioterapi onkologi, yang berfokus pada perawatan pasien kanker dengan radiasi di Rambam Medical Center.

• Pengalaman bertahun-tahun di bidang onkologi radiasi dan onkologi umum
• Spesialisasi dalam penggunaan radioterapi untuk mengobati kanker
• Berbasis di Rambam Medical Center di Israel
• Menggabungkan keahlian dalam radiasi dan onkologi medis untuk perawatan pasien